EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumors

Frank Jacobsen, Ramesh Pushpadevan, Florian Viehweger, Morton Freytag, Ria Schlichter, Natalia Gorbokon, Franziska Büscheck, Andreas M Luebke, Devita Putri, Martina Kluth, Claudia Hube-Magg, Andrea Hinsch und 14 weitere

Pathology - Research and Practice · 2024-04 · 256 · 155175

DOI: 10.1016/j.prp.2024.155175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024-04. Verfasst von Frank Jacobsen und 25 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Adenocarcinoma, Colorectal Neoplasms, Pancreatic Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cadherin-17 (CDH17) is a membranous cell adhesion protein predominantly expressed in intestinal epithelial cells. CDH17 is therefore considered a possible diagnostic and therapeutic target. This study was to comprehensively determine the expression of CDH17 in cancer and to further assess the diagnostic utility of CDH17 immunohistochemistry (IHC). A tissue microarray containing 14,948 interpretable samples from 150 different tumor types and subtypes as well as 76 different normal tissue types was analyzed by IHC. In normal tissues, a membranous CDH17 staining was predominantly seen in the epithelium of the intestine and pancreatic excretory ducts. In tumors, 53 of 150 analyzed categories showed CDH17 positivity including 26 categories with at least one strongly positive case. CDH17 positivity was most common in epithelial and neuroendocrine colorectal neoplasms (50.0%-100%), other gastrointestinal adenocarcinomas (42.7%-61.6%), mucinous ovarian cancer (61.1%), pancreatic acinar cell carcinoma (28.6%), cervical adenocarcinoma (52.6%), bilio-pancreatic adenocarcinomas (40.5-69.8%), and other neuroendocrine neoplasms (5.6%-100%). OnIy 9.9% of 182 pulmonary adenocarcinomas were CDH17 positive. In colorectal adenocarcinomas, reduced CDH17 staining was linked to high pT (p = 0.0147), nodal metastasis (p = 0.0041), V1 (p = 0.0025), L1 (p = 0.0054), location in the right colon (p = 0.0033), and microsatellite instability (p < 0.0001). The CDH17 expression level was unrelated to tumor phenotype in gastric and pancreatic cancer. In summary, our comprehensive overview on CDH17 expression in human tumors identified various tumor entities that might often benefit from anti-CDH17 therapies and suggest utility of CDH17 IHC for the distinction of metastatic gastrointestinal or bilio-pancreatic adenocarcinomas (often positive) from primary pulmonary adenocarcinomas (mostly negative).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaColorectal NeoplasmsPancreatic NeoplasmsHumansCadherinsImmunohistochemistryBiomarkers, Tumor

Substanzen

CadherinsBiomarkers, TumorCDH17 protein, human

Autor:innen und Institutionen

  • Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Pathology, Clinical Center Osnabrueck, Osnabrueck, Germany.
  • Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: R.Simon@uke.de.
  • Department of Pathology, Academic Hospital Fuerth, Fuerth, Germany.

Zitieren

APA

Jacobsen, F., Pushpadevan, R., Viehweger, F., Freytag, M., Schlichter, R., Gorbokon, N., Büscheck, F., Luebke, A. M., Putri, D., Kluth, M., Hube-Magg, C., Hinsch, A., Höflmayer, D., Fraune, C., Bernreuther, C., Lebok, P., Sauter, G., Minner, S., Steurer, S., …, & Clauditz, T. S. (2024). Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumors. Pathology - Research and Practice, 256, 155175. https://doi.org/10.1016/j.prp.2024.155175

Vancouver

Jacobsen F, Pushpadevan R, Viehweger F, Freytag M, Schlichter R, Gorbokon N, et al. Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumors. Pathology - Research and Practice. 2024;256:155175. doi:10.1016/j.prp.2024.155175

BibTeX
@article{Jacobsen2024,
  author = {Jacobsen, Frank and Pushpadevan, Ramesh and Viehweger, Florian and Freytag, Morton and Schlichter, Ria and Gorbokon, Natalia and Büscheck, Franziska and Luebke, Andreas M and Putri, Devita and Kluth, Martina and Hube-Magg, Claudia and Hinsch, Andrea and Höflmayer, Doris and Fraune, Christoph and Bernreuther, Christian and Lebok, Patrick and Sauter, Guido and Minner, Sarah and Steurer, Stefan and Simon, Ronald and Burandt, Eike and Dum, David and Lutz, Florian and Marx, Andreas H and Krech, Till and Clauditz, Till S},
  title = {Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumors},
  journal = {Pathology - Research and Practice},
  year = {2024},
  volume = {256},
  pages = {155175},
  doi = {10.1016/j.prp.2024.155175}
}
Kostenlos starten →